Clinical Trial Update: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 dose-evaluation study of the latanoprost punctal plug delivery system (L-PPDS) in subjects with glaucoma or oc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Glaucoma, Ocular Hypertension (OH) | Phase 2 | Status: COMPLETED